Papers associated with gria2

???displayGene.coCitedPapers???
1 ???displayGene.morpholinoPapers???

???pagination.result.count???

???pagination.result.page??? 1 2 ???pagination.result.next???

Sort Newest To Oldest

Sort Oldest To Newest

	Excitatory synaptic dysfunction cell-autonomously decreases inhibitory inputs and disrupts structural and functional plasticity., He HY, Shen W, Zheng L, Guo X, Cline HT., Nat Commun. July 24, 2018; 9 (1): 2893.
	Role of the visual experience-dependent nascent proteome in neuronal plasticity., Liu HH, McClatchy DB, Schiapparelli L, Shen W, Yates JR, Cline HT., Elife. February 7, 2018; 7
	A molecular atlas of the developing ectoderm defines neural, neural crest, placode, and nonneural progenitor identity in vertebrates., Plouhinec JL, Medina-Ruiz S, Borday C, Bernard E, Vert JP, Eisen MB, Harland RM, Monsoro-Burq AH., PLoS Biol. October 19, 2017; 15 (10): e2004045.
	The biochemical anatomy of cortical inhibitory synapses., Heller EA, Zhang W, Selimi F, Earnheart JC, Ślimak MA, Santos-Torres J, Ibañez-Tallon I, Aoki C, Chait BT, Heintz N., PLoS One. January 1, 2012; 7 (6): e39572.
	Ionotropic glutamate receptor AMPA 1 is associated with ovulation rate., Sugimoto M, Sasaki S, Watanabe T, Nishimura S, Ideta A, Yamazaki M, Matsuda K, Yuzaki M, Sakimura K, Aoyagi Y, Sugimoto Y., PLoS One. November 3, 2010; 5 (11): e13817.
	Regulation of AMPA receptor trafficking by O-glycosylation., Kanno T, Yaguchi T, Nagata T, Mukasa T, Nishizaki T., Neurochem Res. May 1, 2010; 35 (5): 782-8.
	DCP-LA stimulates AMPA receptor exocytosis through CaMKII activation due to PP-1 inhibition., Kanno T, Yaguchi T, Nagata T, Tanaka A, Nishizaki T., J Cell Physiol. October 1, 2009; 221 (1): 183-8.
	Co-expression of Argonaute2 Enhances Short Hairpin RNA-induced RNA Interference in Xenopus CNS Neurons In Vivo., Chen CM, Chiu SL, Shen W, Cline HT., Front Neurosci. July 9, 2009; 3 63.
	Hemichannel-mediated and pH-based feedback from horizontal cells to cones in the vertebrate retina., Fahrenfort I, Steijaert M, Sjoerdsma T, Vickers E, Ripps H, van Asselt J, Endeman D, Klooster J, Numan R, ten Eikelder H, von Gersdorff H, Kamermans M., PLoS One. June 30, 2009; 4 (6): e6090.
	Translational regulation of GluR2 mRNAs in rat hippocampus by alternative 3' untranslated regions., Irier HA, Shaw R, Lau A, Feng Y, Dingledine R., J Neurochem. April 1, 2009; 109 (2): 584-94.
	Stargazin interaction with alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptors is critically dependent on the amino acid at the narrow constriction of the ion channel., Körber C, Werner M, Hoffmann J, Sager C, Tietze M, Schmid SM, Kott S, Hollmann M., J Biol Chem. June 29, 2007; 282 (26): 18758-66.
	A tetrazolyl-substituted subtype-selective AMPA receptor agonist., Vogensen SB, Frydenvang K, Greenwood JR, Postorino G, Nielsen B, Pickering DS, Ebert B, Bølcho U, Egebjerg J, Gajhede M, Kastrup JS, Johansen TN, Clausen RP, Krogsgaard-Larsen P., J Med Chem. May 17, 2007; 50 (10): 2408-14.
	Electrophysiological properties of AMPA receptors are differentially modulated depending on the associated member of the TARP family., Kott S, Werner M, Körber C, Hollmann M., J Neurosci. April 4, 2007; 27 (14): 3780-9.
	Cyclophane and acyclic cyclophane: novel channel blockers of N-methyl-D-aspartate receptor., Masuko T, Nagaoka H, Miyake M, Metori K, Kizawa Y, Kashiwagi K, Igarashi K, Kusama T., Neurochem Int. January 1, 2007; 50 (2): 443-9.
	CPEB3 and CPEB4 in neurons: analysis of RNA-binding specificity and translational control of AMPA receptor GluR2 mRNA., Huang YS, Kan MC, Lin CL, Richter JD., EMBO J. October 18, 2006; 25 (20): 4865-76.
	Measurement of conformational changes accompanying desensitization in an ionotropic glutamate receptor., Armstrong N, Jasti J, Beich-Frandsen M, Gouaux E., Cell. October 6, 2006; 127 (1): 85-97.
	AMPA receptors regulate experience-dependent dendritic arbor growth in vivo., Haas K, Li J, Cline HT., Proc Natl Acad Sci U S A. August 8, 2006; 103 (32): 12127-31.
	3-hydroxypyridazine 1-oxides as carboxylate bioisosteres: a new series of subtype-selective AMPA receptor agonists., Greenwood JR, Mewett KN, Allan RD, Martín BO, Pickering DS., Neuropharmacology. July 1, 2006; 51 (1): 52-9.
	Crystal structures of the kainate receptor GluR5 ligand binding core dimer with novel GluR5-selective antagonists., Mayer ML, Ghosal A, Dolman NP, Jane DE., J Neurosci. March 15, 2006; 26 (11): 2852-61.
	A binding site tyrosine shapes desensitization kinetics and agonist potency at GluR2. A mutagenic, kinetic, and crystallographic study., Holm MM, Naur P, Vestergaard B, Geballe MT, Gajhede M, Kastrup JS, Traynelis SF, Egebjerg J., J Biol Chem. October 21, 2005; 280 (42): 35469-76.
	Tetrazolyl isoxazole amino acids as ionotropic glutamate receptor antagonists: synthesis, modelling and molecular pharmacology., Frølund B, Greenwood JR, Holm MM, Egebjerg J, Madsen U, Nielsen B, Bräuner-Osborne H, Stensbøl TB, Krogsgaard-Larsen P., Bioorg Med Chem. September 15, 2005; 13 (18): 5391-8.
	Structural determinants of agonist-specific kinetics at the ionotropic glutamate receptor 2., Holm MM, Lunn ML, Traynelis SF, Kastrup JS, Egebjerg J., Proc Natl Acad Sci U S A. August 23, 2005; 102 (34): 12053-8.
	Mechanism of partial agonist action at the NR1 subunit of NMDA receptors., Inanobe A, Furukawa H, Gouaux E., Neuron. July 7, 2005; 47 (1): 71-84.
	Identification of subunit- and antagonist-specific amino acid residues in the N-Methyl-D-aspartate receptor glutamate-binding pocket., Kinarsky L, Feng B, Skifter DA, Morley RM, Sherman S, Jane DE, Monaghan DT., J Pharmacol Exp Ther. June 1, 2005; 313 (3): 1066-74.
	Molecular constituents of neuronal AMPA receptors., Fukata Y, Tzingounis AV, Trinidad JC, Fukata M, Burlingame AL, Nicoll RA, Bredt DS., J Cell Biol. May 9, 2005; 169 (3): 399-404.
	Structural features of the glutamate binding site in recombinant NR1/NR2A N-methyl-D-aspartate receptors determined by site-directed mutagenesis and molecular modeling., Chen PE, Geballe MT, Stansfeld PJ, Johnston AR, Yuan H, Jacob AL, Snyder JP, Traynelis SF, Wyllie DJ., Mol Pharmacol. May 1, 2005; 67 (5): 1470-84.
	Exploring the GluR2 ligand-binding core in complex with the bicyclical AMPA analogue (S)-4-AHCP., Nielsen BB, Pickering DS, Greenwood JR, Brehm L, Gajhede M, Schousboe A, Kastrup JS., FEBS J. April 1, 2005; 272 (7): 1639-48.
	Tyr702 is an important determinant of agonist binding and domain closure of the ligand-binding core of GluR2., Frandsen A, Pickering DS, Vestergaard B, Kasper C, Nielsen BB, Greenwood JR, Campiani G, Fattorusso C, Gajhede M, Schousboe A, Kastrup JS., Mol Pharmacol. March 1, 2005; 67 (3): 703-13.
	Anthraquinone polyamines: novel channel blockers to study N-methyl-D-aspartate receptors., Kashiwagi K, Tanaka I, Tamura M, Sugiyama H, Okawara T, Otsuka M, Sabado TN, Williams K, Igarashi K., J Pharmacol Exp Ther. June 1, 2004; 309 (3): 884-93.
	Inhibition of glutamate receptor 2 translation by a polymorphic repeat sequence in the 5'-untranslated leaders., Myers SJ, Huang Y, Genetta T, Dingledine R., J Neurosci. April 7, 2004; 24 (14): 3489-99.
	Ethanol sensitivity of recombinant homomeric and heteromeric AMPA receptor subunits expressed in Xenopus oocytes., Akinshola BE, Yasuda RP, Peoples RW, Taylor RE., Alcohol Clin Exp Res. December 1, 2003; 27 (12): 1876-83.
	Structural basis for partial agonist action at ionotropic glutamate receptors., Jin R, Banke TG, Mayer ML, Traynelis SF, Gouaux E., Nat Neurosci. August 1, 2003; 6 (8): 803-10.
	Identification of a site in GluR1 and GluR2 that is important for modulation of deactivation and desensitization., Leever JD, Clark S, Weeks AM, Partin KM., Mol Pharmacol. July 1, 2003; 64 (1): 5-10.
	Structural model of the N-methyl-D-aspartate receptor glycine site probed by site-directed chemical coupling., Foucaud B, Laube B, Schemm R, Kreimeyer A, Goeldner M, Betz H., J Biol Chem. June 27, 2003; 278 (26): 24011-7.
	Tuning activation of the AMPA-sensitive GluR2 ion channel by genetic adjustment of agonist-induced conformational changes., Armstrong N, Mayer M, Gouaux E., Proc Natl Acad Sci U S A. May 13, 2003; 100 (10): 5736-41.
	(S)-2-Amino-3-(3-hydroxy-7,8-dihydro-6H-cyclohepta[d]isoxazol-4-yl)propionic acid, a potent and selective agonist at the GluR5 subtype of ionotropic glutamate receptors. Synthesis, modeling, and molecular pharmacology., Brehm L, Greenwood JR, Hansen KB, Nielsen B, Egebjerg J, Stensbøl TB, Bräuner-Osborne H, Sløk FA, Kronborg TT, Krogsgaard-Larsen P., J Med Chem. April 10, 2003; 46 (8): 1350-8.
	Mechanism of activation and selectivity in a ligand-gated ion channel: structural and functional studies of GluR2 and quisqualate., Jin R, Horning M, Mayer ML, Gouaux E., Biochemistry. December 31, 2002; 41 (52): 15635-43.
	The aniracetam metabolite 2-pyrrolidinone induces a long-term enhancement in AMPA receptor responses via a CaMKII pathway., Nishizaki T, Matsumura T., Brain Res Mol Brain Res. January 31, 2002; 98 (1-2): 130-4.
	Does acetaldehyde mediate ethanol action in the central nervous system?, Mascia MP, Maiya R, Borghese CM, Lobo IA, Hara K, Yamakura T, Gong DH, Beckstead MJ., Alcohol Clin Exp Res. November 1, 2001; 25 (11): 1570-5.
	Point mutations identify the glutamate binding pocket of the N-methyl-D-aspartate receptor as major site of conantokin-G inhibition., Wittekindt B, Malany S, Schemm R, Otvos L, Maccecchini ML, Laube B, Betz H., Neuropharmacology. November 1, 2001; 41 (6): 753-61.
	Regulation of kinetic properties of GluR2 AMPA receptor channels by alternative splicing., Koike M, Tsukada S, Tsuzuki K, Kijima H, Ozawa S., J Neurosci. March 15, 2000; 20 (6): 2166-74.
	The contributions of GluR2 to allosteric modulation of AMPA receptors., Cotton JL, Partin KM., Neuropharmacology. January 1, 2000; 39 (1): 21-31.
	Arachidonic acid potentiates currents through Ca2+-permeable AMPA receptors by interacting with a CaMKII pathway., Nishizaki T, Matsuoka T, Nomura T, Enikolopov G, Sumikawa K., Brain Res Mol Brain Res. April 6, 1999; 67 (1): 184-9.
	Pharmacological detection of AMPA receptor heterogeneity by use of two allosteric potentiators in rat hippocampal cultures., Sekiguchi M, Takeo J, Harada T, Morimoto T, Kudo Y, Yamashita S, Kohsaka S, Wada K., Br J Pharmacol. April 1, 1998; 123 (7): 1294-303.
	Antagonist properties of a phosphono isoxazole amino acid at glutamate R1-4 (R,S)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid receptor subtypes., Wahl P, Anker C, Traynelis SF, Egebjerg J, Rasmussen JS, Krogsgaard-Larsen P, Madsen U., Mol Pharmacol. March 1, 1998; 53 (3): 590-6.
	Block of open channels of recombinant AMPA receptors and native AMPA/kainate receptors by adamantane derivatives., Magazanik LG, Buldakova SL, Samoilova MV, Gmiro VE, Mellor IR, Usherwood PN., J Physiol. December 15, 1997; 505 ( Pt 3) 655-63.
	Differential dependence on GluR2 expression of three characteristic features of AMPA receptors., Washburn MS, Numberger M, Zhang S, Dingledine R., J Neurosci. December 15, 1997; 17 (24): 9393-406.
	N-Glycosylation is not a prerequisite for glutamate receptor function but Is essential for lectin modulation., Everts I, Villmann C, Hollmann M., Mol Pharmacol. November 1, 1997; 52 (5): 861-73.
	Thiocyanate ions inhibit AMPA-activated currents in recombinant non-NMDA receptors expressed in Xenopus laevis oocytes: the role of the GluR2 subunit., Eugène D, Moss SJ, Smart TG., Eur J Neurosci. September 1, 1996; 8 (9): 1983-93.
	Block of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors by polyamines and polyamine toxins., Washburn MS, Dingledine R., J Pharmacol Exp Ther. August 1, 1996; 278 (2): 669-78.

???pagination.result.page??? 1 2 ???pagination.result.next???